vimarsana.com

Latest Breaking News On - Lifesciences corporation - Page 1 : vimarsana.com

Edwards Lifesciences Co (NYSE:EW) VP Donald E Bobo, Jr Sells 5,000 Shares

Edwards Lifesciences Co. (NYSE:EW – Get Free Report) VP Donald E. Bobo, Jr. sold 5,000 shares of the company’s stock in a transaction dated Wednesday, June 12th. The stock was sold at an average price of $87.54, for a total value of $437,700.00. Following the completion of the sale, the vice president now directly owns […]

Cassaday & Co Wealth Management LLC Buys New Position in Edwards Lifesciences Co (NYSE:EW)

Cassaday & Co Wealth Management LLC purchased a new position in Edwards Lifesciences Co. (NYSE:EW – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 2,648 shares of the medical research company’s stock, valued at approximately $202,000. A number […]

Angeles Investment Advisors LLC Takes $324,000 Position in Edwards Lifesciences Co (NYSE:EW)

Angeles Investment Advisors LLC bought a new stake in Edwards Lifesciences Co. (NYSE:EW – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 4,249 shares of the medical research company’s stock, valued at approximately $324,000. Several other institutional investors have […]

Security National Bank Takes $50,000 Position in Edwards Lifesciences Co (NYSE:EW)

Security National Bank acquired a new stake in Edwards Lifesciences Co. (NYSE:EW – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 655 shares of the medical research company’s stock, valued at approximately $50,000. Several other large […]

Security National Bank Acquires Shares of 655 Edwards Lifesciences Co (NYSE:EW)

Security National Bank purchased a new stake in Edwards Lifesciences Co. (NYSE:EW – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 655 shares of the medical research company’s stock, valued at approximately $50,000. A number of other […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.